OTC future for canker sore patch?
This article was originally published in The Tan Sheet
Executive Summary
Oral canker sore delivery vehicle OraDisc A, "which adheres to the disease site and slowly degrades, releasing the drug locally," eventually could be marketed OTC, Access Pharmaceuticals says. Although firm has been in negotiations with "numerous consumer/pharmaceutical organizations globally" to develop OTC version of oral delivery vehicle for amlexanox, details and timing of such a move remain uncertain, Access says. Final Phase III study for Rx version "has commenced and completion is anticipated by the end of 2002," company notes...